carboxyamidotriazole orotate
Small moleculeexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2010 (NCT01107522)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Vascular endothelial growth factor CANTAGONIST
VEGFC antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- carboxyamidotriazole orotate
- carboxyamidotriazole orotate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01989052 | Phase 1 | May 1, 2014 | Duke University, Tactical Therapeutics, Inc. |
| NCT01954030 | Phase 1 | Oct 1, 2013 | Duke University, Tactical Therapeutics, Inc. |
| NCT01107522 | Phase 1 | May 1, 2010 | Cornell University, New York University, Oregon Health and Science University, Providence Health & Services, Tactical Therapeutics, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tactical Therapeutics, Inc. | For profit | 3 | 1 | 1 | 2010 |
| Duke University | Academic/Hospital | 2 | 2 | 1 | 2013 |
| Cornell University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| New York University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Oregon Health and Science University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Providence Health & Services | Academic/Hospital | 1 | 0 | 1 | 2010 |
6 organizations
Page 1 / 1